Drug intelligence / Profile preview

vitamin b complex + iron

Development stage: Unknown
Lead developer: Chemidrug
Modality: Small Molecules
Administration: Oral

Overview

Vitamin B Complex + Iron (Chemidrug) is an oral combination pharmaceutical product manufactured by Chemidrug Industries Private Limited in Nepal. It is designed to address nutritional deficiencies and support the treatment of iron-deficiency anaemia. The formulation typically includes various B vitamins (such as B1, B2, B3, B5, B6, B12, and Folic Acid) alongside an iron salt. Iron serves as a critical component for the synthesis of hemoglobin in red blood cells, while the B-complex vitamins act as cofactors in numerous metabolic processes, including DNA synthesis and erythropoiesis, ensuring the proper maturation and function of blood cells.

Other names: Vitamin B Complex with IronHaematinic B-Complex

Targets

MTR (Methionine synthase)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on vitamin b complex + iron.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on vitamin b complex + iron.

Explore the full profile